Six Indian pharma stocks entered Bernstein's coverage, with Zydus Lifesciences as the top pick. The brokerage identifies AI-led innovation as a primary growth driver for the healthcare sector. This shift suggests a transition toward algorithmic drug discovery. Investors now track how these firms integrate machine learning into their R&D pipelines.